OpenAI & Anthropic Launch AI Healthcare Products, sparking Industry Debate
Table of Contents
The race to integrate artificial intelligence into healthcare is heating up, with OpenAI and Anthropic both unveiling significant new products within days of each other. These announcements, timed to coincide with the tail end of the Consumer Electronics Show (CES) and the J.P. Morgan Healthcare Conference (JPM), signal a major push to transform both clinical practice and personal health management. While both companies aim to leverage the power of generative AI, their approaches and current capabilities differ.
OpenAI announced ChatGPT for Healthcare, targeting both healthcare institutions and individual consumers. The provider-focused version is being piloted with major healthcare systems including AdventHealth, Baylor Scott & White Health, Boston Children’s hospital, Cedars-Sinai Medical Center, HCA Healthcare, Memorial Sloan Kettering Cancer Center, Stanford Medicine Children’s health, and the University of California, San Francisco.
ChatGPT for Healthcare is designed to alleviate the burdens faced by clinicians and streamline administrative processes. Key features include models specifically built for healthcare workflows, leveraging the power of GPT-5, and the ability to retrieve evidence from millions of peer-reviewed studies, public health guidance documents, and clinical guidelines with clear citations. The system also offers institutional policy and care pathway alignment, integration with tools like microsoft SharePoint, workflow automation templates, robust access management, and support for HIPAA compliance.According to a company release, openai’s API is already powering HIPAA-compliant healthcare software from companies like Abridge, Ambience, and EliseAI.
A consumer-facing version, ChatGPT for Health, is currently in testing. This version will provide a secure space to connect personal medical records and wellness apps, aiming to help individuals understand test results, prepare for appointments, receive personalized advice on diet and exercise, and navigate insurance options. OpenAI intends to operate this service as a separate entity to protect user data and prevent its use in model training. Currently, access is limited to a waitlist, with invitations extended to select users across OpenAI’s product ecosystem, and availability is restricted to the US.
Anthropic’s Claude for Healthcare: A dual Approach for Providers and consumers
Days later, Anthropic, the company behind the agentic AI Claude, announced Claude for Healthcare at JPM, making a strategic move to compete with OpenAI on both the provider and consumer fronts. Built on the latest Opus 4.5 software and leveraging their October release for Life Sciences, Claude’s tools for providers focus on streamlining tasks like prior authorization, insurance claims appeals, care coordination, patient triaging, clinical governance, and supporting healthcare startup developers. The system integrates data from the CMS Coverage Database, ICD-10, and the National Provider Identifier (NPI) Registry.
For individual users, Claude Pro and Max subscribers in the US can now connect their personal health records to Claude. Integrations,or “connectors,” include HealthEx and Function (currently in beta),with Apple Health and Android Health Connect integrations planned for beta release via the Claude iOS and Android apps. Once connected, “Claude can summarize users’ medical history, explain test results in plain language, detect patterns across fitness and health metrics, and prepare questions for appointments,” according to an Anthropic release. This immediate connectivity for individuals gives Claude a current advantage over OpenAI’s still-limited consumer offering.
The PR Battle and a Glimpse of AI’s Potential
Both OpenAI and Anthropic represent “9000-lb elephants” entering the healthcare arena, and the extent of adoption, debugging timelines, and the advancement of viable clinical models remain to be seen. One analyst noted that anthropic appears to have won the initial public relations battle with its JPM announcement, as evidenced by coverage in CNBC and Mobihealthnews. However, a particularly compelling demonstration of Claude’s capabilities emerged from the Food is Health Revolution blog, where a writer detailed how Claude, after analyzing 60 files accumulated over a decade, generated a 12-page health plan that successfully linked their low thyroid function to cognitive issues – a powerful example of AI’s potential to “connect the dots” in complex medical cases.
